Stent: Evolution
Timeline
The milestones of the product, each with a source
| Year | Event |
|---|---|
| 1977 | Andreas Gruntzig performs the first percutaneous coronary intervention, with a balloon, in September [2] |
| 1986 | Jacques Puel, in France, and Ulrich Sigwart introduce metallic coronary stents into clinical practice; Puel's first stent goes in in March [2][8] |
| 1993 | The FDA approves Cook's Gianturco-Roubin coronary stent, already marketed in Australia, Korea and Singapore [6][22] |
| 1994 | The FDA approves the Palmaz-Schatz stent and J&J launches it in the United States [8][7] |
| 1999 | The first drug-eluting stent is implanted [7] |
| 2003 | The Cypher is the first drug-eluting stent approved by the FDA [8] |
| 2011 | Abbott's Absorb bioresorbable scaffold receives a CE mark in January [7] |
| 2016 | The FDA approves the Absorb in July [7] |
| 2017 | India's NPPA caps coronary stent prices under notification S.O. 412(E) of 13 February [11] |
as of 2026-11-13
Lineage
The products and technologies it evolved from and into
Evolved from- Stn Coronary stent The twin technology page holds the working principle and history; this node covers the stent as goods.
as of 2026-11-13
Recipe changes
How what it is made of changed over time, and what drove each change
| Change | From | To | Driver | Source |
|---|---|---|---|---|
| Metal platform and strut thickness | Stainless steel with struts of 130 to 150 µm | Cobalt-chromium and platinum-chromium alloys with struts of 50 to 90 µm | Thinner struts reduced vascular damage while keeping radial strength [6][2] | [6][2] |
| Drug coating | Durable polymer carriers | Biodegradable polymer coatings made from lactic or glycolic acids, which dissolve once the drug is released, in some designs | The sources opened name no single reason [2] | [2] |
| Bare metal to drug-eluting | Bare metal stents | Drug-eluting stents, which at first shared the stainless-steel backbone of bare metal ones (approved in the early 2000s) | A drug on the stent to deal with re-narrowing [5] | [5] |
| Permanent metal to dissolving scaffold | Permanent metal stents | Bioresorbable scaffolds such as the Absorb, with thick struts (150 µm against 81 µm for the Xience) | Scaffold made to dissolve; development was reported to have failed to achieve further clinical benefits [6][5] | [6][5] |
as of 2026-11-13
What could improve it next
Directions for improvement, today's value and the limit
| Direction | Metric | Today | Unit | Source |
|---|---|---|---|---|
| Thinner struts in drug-eluting stents | Strut thickness of the Xience cobalt-chromium stent | 81 | µm | [6] |
| Zinc and magnesium dissolving scaffolds under study | Strut thickness of the Absorb scaffold, the dissolving design to improve on | 150 | µm | [6][5] |
as of 2026-11-13
Sources
- State of the art: coronary artery stents – past, present and future EuroIntervention (Stefanini, Byrne, Windecker and Kastrati), 2017, EuroIntervention 2017;13:706-716
- Modern Stents: Where Are We Going? Rambam Maimonides Medical Journal (Kobo and others), 2020, RMMJ 2020;11(2):e0017, DOI 10.5041/RMMJ.10403
- Inception of the coronary stent: a story of successful collaboration between innovative scientists and the biotechnology industry REC: Interventional Cardiology 6(4):321-331 (Macaya-Ten, Gonzalo, Escaned, Macaya), 2024
- The Surprising History Behind an Extremely Common Cardiovascular Medical Device MD+DI, no byline or date shown on the page
- Stents at 25 years: A revolution in revascularization Healio (Cardiology Today, Brian Ellis), 2011, dated April 01, 2011
- Lok Sabha Unstarred Question No. 2781, Guidelines by NPPA, answered 13 March 2018 Lok Sabha, Ministry of Chemicals and Fertilizers (Department of Pharmaceuticals), 2018
- Cook's Gianturco-Roubin Flex-Stent is first coronary stent approved by FDA (title from the page address; the page text shows no headline) The Gray Sheet, on Medtech Insight (Informa), no date shown; the text gives the FDA panel of May 1992 and approval on 'May 28', which REC (2024) places in 1993